Find annual and quearterly earnings data for J P Morgan Chase & Co (JPM.PRM) including earnings per share, earnings forecasts at Nasdaq.com.
JPM Latest Quarter's Earnings Announce Date 10/11/2024 EPS Normalized Actual $4.81 (Beat by $0.77) EPS GAAP Actual $4.81 (Beat by $0.71) Revenue Actual $42.77B Revenue Surprise Beat by $1.20B JPM Upcoming Quarter's Earnings Announce Date 1/15/2025 (Pre-Market) EPS Normalized Estimate $...
Announcement Date 14/04/23 14/07/23 13/10/23 12/01/24 12/04/24 12/07/24 11/10/24 - - - - - - - - Upcoming sector events for JPMorgan Chase & Co. 2025-01-14 COMMUNITY TRUST BANCORP, INC.: Q4 2024 Earnings Release (Projected) 2025-01-14 INDUSLND BANK LIMITED: Q3 2025...
So, I did want to ask one drill-down question on 2Q, and it's related to the dollar amount of buybacks that you did do. I think in the press release, right, in the slide deck, it's 4.9 billion common stock net repurchases. So, the question here is what's the governor for yo...
JPMorgan Chase & Co (NYSE:JPM) Q3 2022 Earnings Call dated Oct. 14, 2022. Corporate Participants: Jeremy Barnum—Chief Financial Officer James Dimon—Chairman and Chief Executive Officer Analysts: Ken Usdin—Jefferies — Analyst Ebrahim Poonawala—Bank of America Merrill Lynch — Analyst ...
JPM Earnings Preview: Here’s What To Watch For Sheryl ShethJul 08, 2021, 02:18 PM A+ A- JPMorgan Chase & Co. (JPM) is scheduled to report its second-quarter results on July 13 before the market opens. Shares of the company have gained 22% year-to-date, closing at $153.59 on ...
January 17, 2025 · 2 min read · Tristan Manalac Schizophrenia Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS January 17, 2025 · 2 min read · Tristan Manalac Regulatory After Letter to Commissioner, FDA Finally Gives Vanda Reason for Rejection, Chance for Hearing ...
Based on JPMorgan Chase & Co.’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $42.65 billion and a net profit of $12.9 billion. In comparison, last year the company earned a revenue of $39.87 billion and had a net pro...
37、ny.These submissions indicate an exciting time for AstraZeneca,which could see more growth in 2024 as the company awaits the FDA approvals.CEO Pascal Soriot noted in the companys Q3 earnings report that he was excited about the acceleration of the cardiometabolic and obesity pipeline,and this...
It is true that the current seasons, last obs Q4 2013 ratio of negative pre-announcement for the SP500 is rather high at 6.22 for Q1 14, but we find that this pre-announcement ratio is a poor guide of 15% 10 earnings surprises. As mentioned last week, we find that this pre- ...